Bone marrow mesenchymal stem cell-derived exosomal miR-93-5p suppresses esophageal squamous cell carcinoma progression and immune escape through targeting PD-L1
Wenbin Chen, Fangfang Fan, Renliang Fan, Guiju Kong, Yan Wang, Li Zou, Shizhen Wu · 2026
Read Bone marrow mesenchymal stem cell-derived exosomal miR-93-5p suppresses esophageal squamous cell carcinoma progression and immune escape through targeting PD-L1 by Wenbin Chen, Fangfang Fan, Renliang Fan, Guiju Kong, Yan Wang, Li Zou, Shizhen Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13559594.txt.
Description
Wenbin Chen and colleagues test whether exosomes from bone marrow stem cells can slow esophageal squamous cell carcinoma by delivering a microRNA that targets the immune checkpoint PD-L1. Their 2026 study loaded stem cells with extra miR-93-5p, harvested the exosomes they shed, and applied them to two esophageal cancer cell lines. A co-culture system with T cells measured immune escape.
The loaded exosomes cut cancer cell viability, growth, and migration, while raising damaging reactive oxygen species inside the cells. They also lowered PD-L1 at both message and protein level, and three separate assays confirmed the microRNA binds that target directly. T cells killed cancer cells more efficiently once PD-L1 fell. In nude mice, the treatment restrained implanted tumor growth. The authors propose stem cell exosomes as a delivery vehicle for checkpoint-silencing therapy, based so far on laboratory and animal evidence.
Catalog record
| CREATOR | Wenbin Chen, Fangfang Fan, Renliang Fan, Guiju Kong, Yan Wang, Li Zou, Shizhen Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35542 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |